Cogent Biosciences, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Cogent Biosciences, Inc. (COGT) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 45.11 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-10
- Cogent Biosciences, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 45.11M shares, a 29.32% increase year-over-year.
- Cogent Biosciences, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 41.70M shares, a 117.78% increase year-over-year.
- Cogent Biosciences, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 39.85M shares, a 304.54% increase year-over-year.
- Cogent Biosciences, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 38.44M shares, a 394.27% increase year-over-year.
- Cogent Biosciences, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 38.73M shares, a 249.52% increase from fiscal 2020.
- Cogent Biosciences, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 11.08M shares, a 45.42% increase from fiscal 2019.
- Cogent Biosciences, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 7.62M shares, a 69.39% decline from fiscal 2018.
- Cogent Biosciences, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 24.90M shares, a 144.27% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | 45.11M shares 10-Q · filed 2022-05-10 | 43.40M shares derived: average of 2 quarters · filed 2022-05-10 | 42.22M shares derived: average of 3 quarters · filed 2022-05-10 | 41.27M shares derived: average of 4 quarters · filed 2022-05-10 | ||||
| 2021-12-31 | 41.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 40.77M shares derived: average of 2 quarters · filed 2022-03-15 | 40.00M shares derived: average of 3 quarters · filed 2022-03-15 | 38.73M shares 10-K · filed 2022-03-15 | ||||
| 2021-09-30 | 39.85M shares 10-Q · filed 2021-11-10 | 39.15M shares derived: average of 2 quarters · filed 2021-11-10 | 37.74M shares 10-Q · filed 2021-11-10 | 33.08M shares derived: average of 4 quarters · filed 2022-05-10 | ||||
| 2021-06-30 | 38.44M shares 10-Q · filed 2021-08-16 | 36.67M shares 10-Q · filed 2021-08-16 | 30.82M shares derived: average of 3 quarters · filed 2022-05-10 | 25.58M shares derived: average of 4 quarters · filed 2022-05-10 | ||||
| 2021-03-31 | 34.88M shares 10-Q · filed 2022-05-10 | 27.01M shares derived: average of 2 quarters · filed 2022-05-10 | 21.29M shares derived: average of 3 quarters · filed 2022-05-10 | 17.91M shares derived: average of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | 19.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 14.50M shares derived: average of 2 quarters · filed 2022-03-15 | 12.26M shares derived: average of 3 quarters · filed 2022-03-15 | 11.08M shares 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | 9.85M shares 10-Q · filed 2021-11-10 | 8.81M shares derived: average of 2 quarters · filed 2021-11-10 | 8.39M shares 10-Q · filed 2021-11-10 | 8.21M shares derived: average of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | 7.78M shares 10-Q · filed 2021-08-16 | 31.11M shares 10-Q · filed 2020-08-11 | 7.66M shares 10-Q · filed 2021-08-16 | 30.62M shares 10-Q · filed 2020-08-11 | 7.66M shares derived: average of 3 quarters · filed 2021-08-16 | 7.66M shares derived: average of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | 7.53M shares 10-Q · filed 2021-05-12 | 30.14M shares 10-Q · filed 2020-05-11 | 7.60M shares derived: average of 2 quarters · filed 2021-05-12 | 7.62M shares derived: average of 3 quarters · filed 2021-05-12 | 13.34M shares derived: average of 4 quarters · filed 2021-05-12 | |||
| 2019-12-31 | 7.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 7.67M shares derived: average of 2 quarters · filed 2021-03-16 | 15.28M shares derived: average of 3 quarters · filed 2021-03-16 | 7.62M shares 10-K · filed 2021-03-16 | 30.48M shares 10-K · filed 2020-03-26 | |||
| 2019-09-30 | 7.67M shares 10-Q · filed 2020-11-09 | 30.66M shares 10-Q · filed 2019-11-12 | 19.09M shares derived: average of 2 quarters · filed 2020-11-09 | 7.60M shares 10-Q · filed 2020-11-09 | 30.42M shares 10-Q · filed 2019-11-12 | 24.58M shares derived: average of 4 quarters · filed 2020-11-09 | ||
| 2019-06-30 | 30.51M shares 10-Q · filed 2020-08-11 | 30.30M shares 10-Q · filed 2020-08-11 | 30.22M shares derived: average of 3 quarters · filed 2020-08-11 | 30.14M shares derived: average of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | 30.08M shares 10-Q · filed 2020-05-11 | 30.08M shares derived: average of 2 quarters · filed 2020-05-11 | 30.01M shares derived: average of 3 quarters · filed 2020-05-11 | 29.80M shares derived: average of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | 30.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | 29.98M shares derived: average of 2 quarters · filed 2020-03-26 | 29.70M shares derived: average of 3 quarters · filed 2020-03-26 | 24.90M shares 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | 29.88M shares 10-Q · filed 2019-11-12 | 29.52M shares derived: average of 2 quarters · filed 2019-11-12 | 23.17M shares 10-Q · filed 2019-11-12 | 19.86M shares derived: average of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | 29.16M shares 10-Q · filed 2019-08-12 | 19.73M shares 10-Q · filed 2019-08-12 | 16.52M shares derived: average of 3 quarters · filed 2019-08-12 | 14.94M shares derived: average of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | 10.20M shares 10-Q · filed 2019-05-13 | 10.20M shares derived: average of 2 quarters · filed 2019-05-13 | 10.20M shares derived: average of 3 quarters · filed 2019-05-13 | 10.20M shares derived: average of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | 10.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | 10.19M shares derived: average of 2 quarters · filed 2019-03-28 | 10.19M shares derived: average of 3 quarters · filed 2019-03-28 | 10.19M shares 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | 10.19M shares 10-Q · filed 2018-11-13 | 10.19M shares derived: average of 2 quarters · filed 2018-11-13 | 10.19M shares 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | 10.19M shares 10-Q · filed 2018-08-13 | 10.19M shares 10-Q · filed 2018-08-13 | ||||||
| 2017-03-31 | 10.19M shares 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |